Letters regarding article by Mehilli et al, "Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel"

被引：0
|
作者：
Chaves, AJ [1 ]
Sousa, AGMR [1 ]
机构：
[1] Inst Dante Pazzanese Cardiol, Invas Cardiol Sect, Sao Paulo, Brazil
来源：
CIRCULATION | 2005年 / 111卷 / 21期
关键词：
D O I：
10.1161/CIRCULATIONAHA.104.529735
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E370 / E370
页数：1
相关论文
共 50 条
  • [1] Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel
    Mehilli, J
    Kastrati, A
    Schühlen, H
    Dibra, A
    Dotzer, F
    von Beckerath, N
    Bollwein, H
    Pache, J
    Dirschinger, J
    Berger, PP
    Schömig, A
    [J]. CIRCULATION, 2004, 110 (24) : 3627 - 3635
  • [2] ISAR-SWEET (Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel)
    Mehilli, J
    [J]. AMERICAN HEART JOURNAL, 2005, 149 (02) : 248 - 249
  • [3] Impact of High Loading Dose of Atorvastatin in Diabetic Patients with Renal Dysfunction Undergoing Elective Percutaneous Coronary Intervention: A Randomized Controlled Trial
    Shehata, Mohamed
    Hamza, Mohamed
    [J]. CARDIOVASCULAR THERAPEUTICS, 2015, 33 (02) : 35 - 41
  • [4] Abciximab and angiographic restenosis after coronary stent placement.: Analysis of the angiographic substudy of ISAR-REACT -: A double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel
    Schuehlen, Helmut
    Kastrati, Adnan
    Mehilli, Julinda
    Hausleiter, Joerg
    Dirschinger, Josef
    Dotzer, Franz
    Bollwein, Hildegard
    Schoemig, Albert
    [J]. AMERICAN HEART JOURNAL, 2006, 151 (06) : 1248 - 1254
  • [5] Impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions:: Results of a randomized study
    Angiolillo, Dominick J.
    Bernardo, Esther
    Costa, Marco A.
    Palazuelos, Jorge
    Desai, Blhaloo
    Weisberg, Ian
    Alfonso, Fernando
    Guzman, Luis A.
    Rozum, Liudmila
    Capranzano, Piera
    Hernandez-Antolin, Rosana
    Zenni, Martin Z.
    Macaya, Carlos
    Fernandez-Ortiz, Antonio
    Bass, Theodore A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B85 - B85
  • [6] Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions -: Results of a randomized study
    Angiolillo, Dominick J.
    Bernardo, Esther
    Palazuelos, Jorge
    Desai, Bhaloo
    Weisberg, Ian
    Alfonso, Fernando
    Guzman, Luis A.
    Hernandez-Antolin, Rosana
    Zenni, Martin Z.
    Macaya, Carlos
    Fernandez-Ortiz, Antonio
    Bass, Theodore A.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2008, 99 (01) : 161 - 168
  • [7] Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment -: The ISAR-REACT 2 randomized trial
    Kastrati, A
    Mehilli, J
    Neumann, FJ
    Dotzer, F
    ten Berg, JN
    Bollwein, H
    Graf, I
    Ibrahim, M
    Pache, J
    Seyfarth, M
    Schühlen, H
    Dirschinger, J
    Berger, PB
    Schömig, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (13): : 1531 - 1538
  • [8] Long-term results of ISAR-REACT: A randomized trial evaluating abciximab in patients with elective percutaneous coronary intervention after pretreatment with a high loading dose of clopiclogrel
    Schuhlen, H
    Kastrati, A
    Mehilli, J
    Dirschinger, J
    Dotzer, F
    ten Berg, J
    Neumann, FJ
    Berger, PB
    Schomig, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 2A - 2A
  • [9] Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention
    Germing, A
    [J]. MEDIZINISCHE KLINIK, 2005, 100 (07) : 425 - 426
  • [10] Letters regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (antiplatelet therapy for reduction of MYocardial damage during angioplasty) study"
    Palabrica, TM
    Burton, PB
    [J]. CIRCULATION, 2005, 112 (17) : E282 - E283
12345